Aytu Biopharma (AYTU) FCF Margin (QoQ) (2014 - 2026)
Aytu Biopharma (AYTU) FCF Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Aytu Biopharma | 24.86 Mn | -1.86 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,782.00 |
| Dec 31, 2025 | 2,857.00 |
| Sep 30, 2025 | -2,286.00 |
| Jun 30, 2025 | 5,376.00 |
| Mar 31, 2025 | -5,323.00 |
| Dec 31, 2024 | 2,587.00 |
| Sep 30, 2024 | -35.00 |
| Jun 30, 2024 | -584.00 |
| Mar 31, 2024 | -109.00 |
| Dec 31, 2023 | 46.00 |
| Sep 30, 2023 | -3,168.00 |
| Jun 30, 2023 | 4,330.00 |
| Mar 31, 2023 | -334.00 |
| Dec 31, 2022 | 2,344.00 |
| Sep 30, 2022 | -706.00 |
| Jun 30, 2022 | 1,182.00 |
| Mar 31, 2022 | 44.00 |
| Dec 31, 2021 | -2,076.00 |
| Sep 30, 2021 | -4,613.00 |
| Dec 31, 2020 | 3,998.00 |